Celanese Q2 EPS Beats by 10%, Guides Q3 Above Street
CE sits 26% above its 52-week low of $35.13 on elevated volume (2.0× avg).
Summary
Celanese delivered a strong Q2, with adjusted EPS of $2.45 beating consensus by $0.22 on sales of $2.75B that met expectations. The beat was driven by higher prices and volumes across both segments, with particular strength in medical and electronics. Management guided Q3 adjusted EPS to $1.35-$1.75, above the $1.30 consensus, and reaffirmed full-year EPS of $6.00 and free cash flow of $700M-$800M. This follows a year of heavy impairment losses and covenant concerns, making the earnings beat and steady guidance a positive signal. The company also highlighted over $50M in annualized cost savings from facility closures and network optimization. With shares trading at just 7x forward earnings, the results support the bull case that the worst is behind them.
At the time of this announcement, CE was trading at $44.20 on NYSE in the Manufacturing sector, with a market capitalization of approximately $5B. The 52-week trading range was $35.13 to $70.70. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.